- Home
- BIVI
BIVI
BioVie Inc.
as 11-21-2024 4:00pm EST
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | CARSON CITY |
| Market Cap: | 45.1M | IPO Year: | N/A |
| Target Price: | $40.00 | AVG Volume (30 days): | 3.3M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.14 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.04 - $56.54 | Next Earning Date: | 11-13-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest BioVie Inc. News
BIVI Breaking Stock News: Dive into BIVI Ticker-Specific Updates for Smart Investing
GlobeNewswire
a day ago
BioVie to Present Design of Planned Phase 2 Study of Bezisterim for the Treatment of Long COVID at the Demystifying Long COVID International Conference
GlobeNewswire
17 days ago
BioVie’s Upcoming Parkinson’s Disease Clinical Trial is Fully Funded
GlobeNewswire
23 days ago
BioVie Inc. Announces Closing of Registered Direct Offering
GlobeNewswire
24 days ago
UPDATE -- BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire
24 days ago
BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire
a month ago
BioVie Inc. Announces Closing of Registered Direct Offering and Concurrent Private Placement
MT Newswires
a month ago
Top Premarket Gainers
GlobeNewswire
a month ago
BioVie Inc. Announces Pricing of Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
Compare BIVI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BIVI BioVie Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.